These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39366554)

  • 1. Drugs targeting SHIP2 demonstrate potent antiproliferative effects irrespective of SHIP2 inhibition.
    El Sayed A; Gomes N; Czerwińska A; Azzi A
    Life Sci; 2024 Nov; 357():123101. PubMed ID: 39366554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scaffold dependent role of the inositol 5'-phosphatase SHIP2, in regulation of oxidative stress induced apoptosis.
    Azzi A
    Arch Biochem Biophys; 2021 Jan; 697():108667. PubMed ID: 33181128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2.
    Suwa A; Yamamoto T; Sawada A; Minoura K; Hosogai N; Tahara A; Kurama T; Shimokawa T; Aramori I
    Br J Pharmacol; 2009 Oct; 158(3):879-87. PubMed ID: 19694723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHIP2 inhibition alters redox-induced PI3K/AKT and MAP kinase pathways via PTEN over-activation in cervical cancer cells.
    Azzi A
    FEBS Open Bio; 2020 Oct; 10(10):2191-2205. PubMed ID: 32881386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AS1949490, an inhibitor of 5'-lipid phosphatase SHIP2, promotes protein kinase C-dependent stabilization of brain-derived neurotrophic factor mRNA in cultured cortical neurons.
    Tsuneki H; Yoshida H; Okamoto K; Yamaguchi M; Endo K; Nakano A; Tsuda M; Toyooka N; Wada T; Sasaoka T
    Eur J Pharmacol; 2019 May; 851():69-79. PubMed ID: 30753865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of SHIP2 in CD2AP-deficient podocytes ameliorates reactive oxygen species generation but aggravates apoptosis.
    Saurus P; Tolvanen TA; Lindfors S; Kuusela S; Holthöfer H; Lehtonen E; Lehtonen S
    Sci Rep; 2017 Sep; 7(1):10731. PubMed ID: 28878342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Functional Roles of the Src Homology 2 Domain-Containing Inositol 5-Phosphatases SHIP1 and SHIP2 in the Pathogenesis of Human Diseases.
    Müller SM; Jücker M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small molecule targeting of SHIP1 and SHIP2.
    Kerr WG; Pedicone C; Dormann S; Pacherille A; Chisholm JD
    Biochem Soc Trans; 2020 Feb; 48(1):291-300. PubMed ID: 32049315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of SH2-Containing Inositol Phosphatase Contributes to Chronic Lymphocytic Leukemia Survival.
    Pal Singh S; de Bruijn MJW; Velaso Gago da Graça C; Corneth OBJ; Rip J; Stadhouders R; Meijers RWJ; Schurmans S; Kerr WG; Ter Burg J; Eldering E; Langerak AW; Pillai SY; Hendriks RW
    J Immunol; 2020 Jan; 204(2):360-374. PubMed ID: 31836657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Descending-SHIP2-mediated radiosensitivity enhancement through PI3K/Akt signaling pathway in laryngeal squamous cell carcinoma.
    Tang T; Xiao ZY; Shan G; Lei HB
    Biomed Pharmacother; 2019 Oct; 118():109392. PubMed ID: 31545285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.
    Artemenko Y; Gagnon A; Sorisky A
    J Cell Physiol; 2009 Jan; 218(1):228-36. PubMed ID: 18814181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia.
    Ecker V; Stumpf M; Brandmeier L; Neumayer T; Pfeuffer L; Engleitner T; Ringshausen I; Nelson N; Jücker M; Wanninger S; Zenz T; Wendtner C; Manske K; Steiger K; Rad R; Müschen M; Ruland J; Buchner M
    Nat Commun; 2021 Jun; 12(1):3526. PubMed ID: 34112805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer.
    Fuhler GM; Brooks R; Toms B; Iyer S; Gengo EA; Park MY; Gumbleton M; Viernes DR; Chisholm JD; Kerr WG
    Mol Med; 2012 Feb; 18(1):65-75. PubMed ID: 22033675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activation.
    Hoekstra E; Das AM; Willemsen M; Swets M; Kuppen PJ; van der Woude CJ; Bruno MJ; Shah JP; Ten Hagen TL; Chisholm JD; Kerr WG; Peppelenbosch MP; Fuhler GM
    Oncotarget; 2016 Nov; 7(45):73525-73540. PubMed ID: 27716613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.
    Tang X; Powelka AM; Soriano NA; Czech MP; Guilherme A
    J Biol Chem; 2005 Jun; 280(23):22523-9. PubMed ID: 15824124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways.
    Huang S; Jin A
    J Cell Biochem; 2018 Feb; 119(2):2248-2257. PubMed ID: 28857346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SH2-domain containing inositol phosphatase 2 (SHIP2) in insulin producing INS1E cells improves insulin signal transduction and induces proliferation.
    Grempler R; Leicht S; Kischel I; Eickelmann P; Redemann N
    FEBS Lett; 2007 Dec; 581(30):5885-90. PubMed ID: 18061583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencer of death domains (SODD) inhibits skeletal muscle and kidney enriched inositol 5-phosphatase (SKIP) and regulates phosphoinositide 3-kinase (PI3K)/Akt signaling to the actin cytoskeleton.
    Rahman P; Huysmans RD; Wiradjaja F; Gurung R; Ooms LM; Sheffield DA; Dyson JM; Layton MJ; Sriratana A; Takada H; Tiganis T; Mitchell CA
    J Biol Chem; 2011 Aug; 286(34):29758-70. PubMed ID: 21712384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.